Literature DB >> 31089864

Spatial Model for Oncolytic Virotherapy with Lytic Cycle Delay.

Jiantao Zhao1,2, Jianjun Paul Tian3,4.   

Abstract

We formulate a mathematical model of functional partial differential equations for oncolytic virotherapy which incorporates virus diffusivity, tumor cell diffusion, and the viral lytic cycle based on a basic oncolytic virus dynamics model. We conduct a detailed analysis for the dynamics of the model and carry out numerical simulations to demonstrate our analytic results. Particularly, we establish the positive invariant domain for the [Formula: see text] limit set of the system and show that the model has three spatially homogenous equilibriums solutions. We prove that the spatially uniform virus-free steady state is globally asymptotically stable for any viral lytic period delay and diffusion coefficients of tumor cells and viruses when the viral burst size is smaller than a critical value. We obtain the conditions, for example the ratio of virus diffusion coefficient to that of tumor cells is greater than a value and the viral lytic cycle, is greater than a critical value, under which the spatially uniform positive steady state is locally asymptotically stable. We also obtain conditions under which the system undergoes Hopf bifurcations, and stable periodic solutions occur. We point out medical implications of our results which are difficult to obtain from models without combining diffusive properties of viruses and tumor cells with viral lytic cycles.

Entities:  

Keywords:  Functional reaction–diffusion equations; Hopf bifurcation; Oncolytic virotherapy; Stability

Mesh:

Year:  2019        PMID: 31089864      PMCID: PMC8890613          DOI: 10.1007/s11538-019-00611-2

Source DB:  PubMed          Journal:  Bull Math Biol        ISSN: 0092-8240            Impact factor:   3.871


  29 in total

1.  Mathematical and Computational Modeling for Tumor Virotherapy with Mediated Immunity.

Authors:  Asim Timalsina; Jianjun Paul Tian; Jin Wang
Journal:  Bull Math Biol       Date:  2017-06-07       Impact factor: 1.758

2.  Viruses as antitumor weapons: defining conditions for tumor remission.

Authors:  D Wodarz
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

Review 3.  Adenovirus-based cancer gene therapy.

Authors:  Johanne M Kaplan
Journal:  Curr Gene Ther       Date:  2005-12       Impact factor: 4.391

Review 4.  Oncolytic viruses.

Authors:  E Antonio Chiocca
Journal:  Nat Rev Cancer       Date:  2002-12       Impact factor: 60.716

5.  Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery.

Authors:  Lawrence M Wein; Joseph T Wu; David H Kirn
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

6.  Glioma virotherapy: effects of innate immune suppression and increased viral replication capacity.

Authors:  Avner Friedman; Jianjun Paul Tian; Giulia Fulci; E Antonio Chiocca; Jin Wang
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

7.  Modeling of cancer virotherapy with recombinant measles viruses.

Authors:  Zeljko Bajzer; Thomas Carr; Kresimir Josić; Stephen J Russell; David Dingli
Journal:  J Theor Biol       Date:  2008-02-01       Impact factor: 2.691

8.  Combination therapy for cancer with oncolytic virus and checkpoint inhibitor: A mathematical model.

Authors:  Avner Friedman; Xiulan Lai
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

9.  Towards predictive computational models of oncolytic virus therapy: basis for experimental validation and model selection.

Authors:  Dominik Wodarz; Natalia Komarova
Journal:  PLoS One       Date:  2009-01-30       Impact factor: 3.240

10.  Virtual brain tumours (gliomas) enhance the reality of medical imaging and highlight inadequacies of current therapy.

Authors:  K R Swanson; E C Alvord; J D Murray
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.